oxaliplatin (Cipla USA Inc.)
Welcome to the PulseAid listing for the oxaliplatin drug offered from Cipla USA Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
| NON-PROPRIETARY NAME: | oxaliplatin |
| SUBSTANCE NAME: | OXALIPLATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-02-10 |
| END MARKETING DATE: | 0000-00-00 |
oxaliplatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | oxaliplatin from Cipla USA Inc. |
| LABELER NAME: | Cipla USA Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2017-02-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69097-274_29b76e82-c9d2-4d76-9d41-da78c12b8360 |
| PRODUCT NDC: | 69097-274 |
| APPLICATION NUMBER: | ANDA208523 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers:
